Truscreen Group Ltd (TRU)

Snapshot

TRU's Principal Activity is the owns the rights to the TruScreen Cervical Cancer Screening Device. The device comprises a medical device and process designed to detect the presence in real time of precancerous and cancerous tissue on the cervix.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
15/10/2013	$0.17	100%	$0.2429	Interim	05/11/2013
29/04/2013	$0.18	100%	$0.2571	Final	17/05/2013
17/10/2012	$0.12	100%	$0.1714	Interim	08/11/2012
02/05/2012	$0.18	100%	$0.2571	Final	24/05/2012
22/11/2011	$0.17	100%	$0.2429	Interim	14/12/2011
27/04/2011	$0.18	100%	$0.2571	Final	16/05/2011
21/10/2010	$0.17	100%	$0.2429	Interim	11/11/2010
05/05/2010	$0.165	100%	$0.2357	Final	25/05/2010
22/10/2009	$0.172	100%	$0.2457	Interim	12/11/2009
30/04/2009	$0.22	100%	$0.3143	Final	20/05/2009

Show All

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM)	$0.00
Gross DPS(TTM)	$0.00
Dividend yield
Gross yield
Payout Ratio	--
DRP	No
DRP Features	-

Directors & Management

Name	Title	Since	Bio
Dr Dexter Cheung	Non-Executive Director	Mar 2021	Dr Dexter Cheung Non-Executive Director Dr Cheung have more than 20 years experience. He is the Research & Development Manager of the respiratory humidification division of Fisher & Paykel Healthcare, an NZX/ASX listed healthcare company and a global leader in respiratory medical devices. Dr Cheung is memeber of Risk and Finance Committee.
Ms Juliet Hull	Chief Executive Officer,Executive Director	Sep 2020	Ms Juliet Hull Chief Executive Officer,Executive Director Ms Hull was until January 2021 the NZ General Manager/ Country Director of Johnson & Johnson Medical (J & J), a director of the ANZ Johnson & Johnson Medical Executive Board, a director of MTANZ (Medical Technology Association of NZ) and amember of both the APAC Regional Leadership team for J & J's Orthopaedics and Ethicon Divisions. Ms Hull is a senior executive with more than 20 years experience in Asia Pacific markets in Healthcare sales, marketing and leadership. Ms Hull is currently acting as the interim CEO of TruScreen.
Mr Guy Adrian Robertson	Chief Financial Officer,Company Secretary	Nov 2018
Mr Anthony (Tony) Peng Ho	Non-Executive Chairman,Non-Executive Director	Oct 2018	Mr Anthony (Tony) Peng Ho Non-Executive Chairman,Non-Executive Director Mr Ho is an experienced company director having held executive directorships and chief financial officer roles with a number of ASX listed companies. Mr Ho was executive director of Arthur Yates & Co Limited, retiring from that position in April 2002. His corporate, general management and governance experience includes being chief financial officer/finance director of M.S. McLeod Holdings Limited, Galore Group Limited, the Edward H O'Brien group of companies. He was previously chairman of Esperance Minerals Limited and Credit Intelligence Limited and a non-executive director Hastings Technology Metals Limited. Mr Ho was the past nonexecutive chairman of St. George Community Housing Limited (November 2002 to December 2009) where he successfully grew the NGO to be one of New South Wales leading community housing companies. Prior to joining commerce, Mr Ho was a partner of Cox Johnston & Co, Chartered Accountants, which has since merged with Ernst & Young.
Mr Christopher Horn	Non-Executive Director	Nov 2013	Mr Christopher Horn Non-Executive Director Mr Horn is an experienced business executive and has acted in a number of management roles including 20 years as a partner of KPMG and its predecessor firms. He is a director of a number of private companies across a broad range of business activities including corporate advisory, financial services and funds management. He is chairman of Finance and Risk Committee.
Guy Robertson	Chief Financial Officer	N/A
Edmond Capcelea	Chief Technology Officer	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
27/09/21	Dexter Cheung	Buy	+100,000	$0.06	$6,030	On-market trade
03/08/21	Christopher (Chris) Lawrence	Sell	+1,406,913	$0.065	($90,869)	On-market trade
29/07/21	Anthony (Tony) Ho	Buy	+100,000	$0.062	$6,200	On-market trade
20/07/21	Christopher (Chris) Lawrence	Sell	+4,467,169	$0.068	($302,302)	On-market trade
12/07/21	Anthony (Tony) Ho	Expiry	1,000,000	$0.068	$68,000	Options expired
02/07/21	Christopher (Chris) Lawrence	Sell	+1,465,695	$0.069	($101,761)	On-market trade
02/06/21	Christopher (Chris) Lawrence	Sell	+418,818	$0.078	($32,736)	On-market trade
06/01/21	Anthony (Tony) Ho	Buy	+100,000	$0.09	$9,000	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Dexter Cheung	27/09/2021	100,000	N/A	N/A	N/A
Anthony (Tony) Ho	29/07/2021	N/A	3,700,000	2,000,000	N/A
Christopher Horn	31/03/2021	2,050,000	N/A	1,000,000	N/A
Juliet Hull	N/A	N/A	N/A	N/A	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
New Zealand Depository Nominee <1 A/C>	30,459,778	8.39%
Consolidated Nominees Pty Ltd <ARF The Robair Investment Trust A/C>	29,539,900	8.14%
Browns Island Holdings Limited	21,658,411	5.97%
Waitara Trustees Limited	18,622,222	5.13%
Masfen Securities Limited	13,499,645	3.72%
New Zealand Central Securities	11,847,611	3.27%
Albert Nominees Limited	11,000,000	3.03%
Consolidated Nominees Pty Ltd <Atk Rkh Superannuation Fund A/C>	10,062,500	2.77%
Idl Trustee Limited	9,850,000	2.71%
Lah Investment Co Pty Limited <Lah Superannuation Fund A/C>	9,056,330	2.50%
Ryan Peter Parkin	5,300,000	1.46%
Maarten Arnold Janssen	4,964,170	1.37%
Forsyth Barr Custodians	4,502,610	1.24%
David Russell Stewart & Adrienne Ruth Stewart	4,138,995	1.14%
Caroline Robyn Ball & Christopher John Thomson Bush	2,978,681	0.82%
Custodial Services Limited <4 A/C>	2,455,999	0.68%
Anthony Peng Ho & Chui Hoong Ho <AP & CH Super Fund A/C>	2,400,000	0.66%
QSP Limited	2,312,790	0.64%
Christopher Lawrence Horn & Marilyn Gai Horn <The C L Horn Super Fund A/C>	2,050,000	0.56%
Margot Jean Ainsworth	2,000,000	0.55%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
No Financial Year End data available

TRU Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.